Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Tuesday, December 3, 2013

bluebird bio Inc admits first patient in Phase 1/2 HGB-205 study of...

Gene therapies company bluebird bio Inc said on Monday that its first subject with beta-thalassemia major has been enrolled in its phase 1/2 HGB-205 study in France.

http://www.m2.com/m2/web/story.php/20133535851
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts